全球兒童和新生兒檢測套組市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球兒童和新生兒檢測套組市場預計將從2025年的47億美元成長至2034年的95.6億美元，2026年至2034年的複合年成長率（CAGR）為8.22%。這個市場持續成長的原因在於，人們對嬰兒童疾病早期診斷和治療重要性的認知不斷提高。醫療專業人員越來越重視新生兒篩檢項目，以便及早發現先天性疾病、感染疾病和代謝性疾病。醫療基礎設施的改善和診斷服務覆蓋範圍的擴大，正在推動已開發國家和開發中國家的市場擴張。預防醫學日益受到重視以及新生兒護理標準的提高，進一步推動了全球對兒童和新生兒檢測套組的需求。

關鍵成長要素包括遺傳疾病發生率上升、部分地區出生率增加、診斷技術的進步。快速檢測、即時診斷和高精度篩檢方案的引入改善了臨床療效並提高了醫療資源利用率。政府促進婦幼健康的措施也顯著推動了市場發展。此外，醫療機構正加大對先進診斷設備和篩檢計畫的投入，為市場成長創造了有利環境。

隨著技術創新不斷提升檢測的準確性、速度和可近性，市場前景依然樂觀。分子診斷、基因組檢測和數位醫療平台的整合有望變革新生兒和兒童篩檢方式。新興經濟體醫療保險覆蓋範圍的擴大以及家長對疾病早期檢測意識的提高，將進一步推動市場需求。隨著醫療體系持續重視預防醫學和個人化治療方案，預計未來幾年該市場將保持持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球兒童和新生兒檢測套組市場：按檢測類型分類

• 市場分析、洞察與預測
• 乾血斑
• 聽力篩檢
• 嚴重先天性心臟疾病（CCHD）
• 其他測試類型

第5章 全球兒童和新生兒檢測套組市場：按產品分類

• 市場分析、洞察與預測
• 檢測試劑盒和試劑
• 裝置

第6章 全球兒童與新生兒檢測套組市場：依技術分類

• 市場分析、洞察與預測
• 串聯式質譜質譜法
• 脈搏血氧計
• 酵素法
• 基於DNA的檢測
• 電泳
• 其他技術

第7章 全球兒童和新生兒檢測套組市場：按最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診斷中心
• 婦產科和專科診所
• 其他最終用戶

第8章 全球兒童和新生兒檢測套組市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • Medtronic Plc
  • Siemens Healthineers
  • GE Healthcare GmbH
  • Eurofins Scientific SE
  • Trivitron Healthcare Pvt Ltd
  • Hologic Inc
  • PerkinElmer Inc
  • Quidel Corporation
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • Natus Medical Incorporated
  • BioFire Diagnostics LLC

The global paediatric and neonatal testing kits market size is expected to reach USD 9.56 Billion in 2034 from USD 4.70 Billion in 2025, growing at a CAGR of 8.22 during 2026-2034.This market has experienced consistent growth due to increasing awareness regarding early diagnosis and treatment of diseases in infants and children. Healthcare providers are placing greater emphasis on neonatal screening programs to detect congenital disorders, infections, and metabolic conditions at an early stage. Improvements in healthcare infrastructure and broader access to diagnostic services have supported market expansion across both developed and developing economies. The growing importance of preventive healthcare and enhanced newborn care standards has further strengthened demand for pediatric and neonatal testing kits globally.

Key growth drivers include rising incidences of genetic disorders, increasing birth rates in several regions, and advancements in diagnostic technologies. The adoption of rapid testing methods, point-of-care diagnostics, and highly accurate screening solutions has improved clinical outcomes and increased utilization. Government initiatives promoting maternal and child healthcare have also contributed significantly to market development. Furthermore, healthcare providers are increasingly investing in modern diagnostic equipment and screening programs, creating favorable conditions for market growth.

Future prospects for the market remain promising as technological innovation continues to improve testing accuracy, speed, and accessibility. The integration of molecular diagnostics, genomic testing, and digital healthcare platforms is expected to transform neonatal and pediatric screening practices. Expanding healthcare coverage in emerging economies and growing awareness among parents regarding early disease detection will further support demand. As healthcare systems continue prioritizing preventive care and personalized treatment approaches, the market is expected to witness sustained growth over the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Test Type

• Dried Blood Spot
• Hearing Screening
• Critical Congenital Heart Defect (CCHD)
• Other Test Types

By Product

• Assay Kits and Reagents
• Instruments

By Technology

• Tandem Mass Spectrometry
• Pulse Oximetry
• Enzyme-Based Assays
• DNA Based Assays
• Electrophoresis
• Other Technologies

By End User

• Hospitals
• Diagnostic Centers
• Maternity and Specialty Clinics
• Other End Users

COMPANIES PROFILED

• F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Siemens Healthineers, GE Healthcare GmbH, Eurofins Scientific SE, Trivitron Healthcare Pvt Ltd., Hologic Inc., PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Natus Medical Incorporated, BioFire Diagnostics LLC

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PAEDIATRIC & NEONATAL TESTING KITS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Dried Blood Spot Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hearing Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Critical Congenital Heart Defect (CCHD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PAEDIATRIC & NEONATAL TESTING KITS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Assay Kits and Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PAEDIATRIC & NEONATAL TESTING KITS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Tandem Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pulse Oximetry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Enzyme-Based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. DNA Based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PAEDIATRIC & NEONATAL TESTING KITS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Maternity and Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PAEDIATRIC & NEONATAL TESTING KITS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Test Type
  • 8.2.2 By Product
  • 8.2.3 By Technology
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Test Type
  • 8.3.2 By Product
  • 8.3.3 By Technology
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Test Type
  • 8.4.2 By Product
  • 8.4.3 By Technology
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Test Type
  • 8.5.2 By Product
  • 8.5.3 By Technology
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Test Type
  • 8.6.2 By Product
  • 8.6.3 By Technology
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PAEDIATRIC & NEONATAL TESTING KITS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 F. Hoffmann-La Roche AG
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 Abbott Laboratories
  • 10.2.4 Medtronic Plc
  • 10.2.5 Siemens Healthineers
  • 10.2.6 GE Healthcare GmbH
  • 10.2.7 Eurofins Scientific SE
  • 10.2.8 Trivitron Healthcare Pvt Ltd
  • 10.2.9 Hologic Inc
  • 10.2.10 PerkinElmer Inc
  • 10.2.11 Quidel Corporation
  • 10.2.12 Bio-Rad Laboratories Inc
  • 10.2.13 QIAGEN NV
  • 10.2.14 Natus Medical Incorporated
  • 10.2.15 BioFire Diagnostics LLC